Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women

H. Gbelcová, P. Bakeš, P. Priščáková, V. Šišovský, I. Hojsíková, Ľ. Straka, M. Konečný, J. Markus, CW. D'Acunto, T. Ruml, D. Böhmer, Ľ. Danihel, V. Repiská,

. 2015 ; 2015 (-) : 746856. [pub] 20150531

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Phosphatase and tensin homolog (PTEN) is a protein that acts as a tumor suppressor by dephosphorylating the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate. Loss of PTEN function has been implicated in the pathogenesis of a number of different tumors, particularly endometrial carcinoma (ECa). ECa is the most common neoplasia of the female genital tract. Our study evaluates an association between the morphological appearance of endometrial hyperplasia and endometrial carcinoma and the degree of PTEN alterations. A total of 45 endometrial biopsies from Slovak women were included in present study. Formalin-fixed and paraffin-embedded tissue samples with simple hyperplasia (3), complex hyperplasia (5), atypical complex hyperplasia (7), endometrioid carcinomas G1 (20) and G3 (5), and serous carcinoma (5) were evaluated for the presence of mutations in coding regions of PTEN gene, the most frequently mutated tumor suppressor gene in endometrial carcinoma. 75% of the detected mutations were clustered in exons 5 and 8. Out of the 39 mutations detected in 24 cases, 20 were frameshifts and 19 were nonsense, missense, or silent mutations. Some specimens harboured more than one mutation. The results of current study on Slovak women were compared to a previous study performed on Polish population. The two sets of results were similar.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010068
003      
CZ-PrNML
005      
20220215110435.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2015/746856 $2 doi
024    7_
$a 10.1155/2015/746856 $2 doi
035    __
$a (PubMed)26114084
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gbelcová, H $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia ; Department of Biochemistry and Microbiology, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Prague, Technicka 5, 16628 Prague, Czech Republic.
245    10
$a PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women / $c H. Gbelcová, P. Bakeš, P. Priščáková, V. Šišovský, I. Hojsíková, Ľ. Straka, M. Konečný, J. Markus, CW. D'Acunto, T. Ruml, D. Böhmer, Ľ. Danihel, V. Repiská,
520    9_
$a Phosphatase and tensin homolog (PTEN) is a protein that acts as a tumor suppressor by dephosphorylating the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate. Loss of PTEN function has been implicated in the pathogenesis of a number of different tumors, particularly endometrial carcinoma (ECa). ECa is the most common neoplasia of the female genital tract. Our study evaluates an association between the morphological appearance of endometrial hyperplasia and endometrial carcinoma and the degree of PTEN alterations. A total of 45 endometrial biopsies from Slovak women were included in present study. Formalin-fixed and paraffin-embedded tissue samples with simple hyperplasia (3), complex hyperplasia (5), atypical complex hyperplasia (7), endometrioid carcinomas G1 (20) and G3 (5), and serous carcinoma (5) were evaluated for the presence of mutations in coding regions of PTEN gene, the most frequently mutated tumor suppressor gene in endometrial carcinoma. 75% of the detected mutations were clustered in exons 5 and 8. Out of the 39 mutations detected in 24 cases, 20 were frameshifts and 19 were nonsense, missense, or silent mutations. Some specimens harboured more than one mutation. The results of current study on Slovak women were compared to a previous study performed on Polish population. The two sets of results were similar.
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a hyperplazie endometria $x genetika $7 D004714
650    _2
$a nádory endometria $x genetika $7 D016889
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a molekulární sekvence - údaje $7 D008969
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a mutační rychlost $7 D059645
650    _2
$a fosfohydroláza PTEN $x genetika $7 D051059
650    12
$a sekvenční analýza DNA $7 D017422
651    _2
$a Slovenská republika $7 D018154
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bakeš, P $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia.
700    1_
$a Priščáková, P $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia.
700    1_
$a Šišovský, V $u Institute of Pathological Anatomy, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia.
700    1_
$a Hojsíková, I $u MEDIREX GROUP ACADEMY n.o., Galvaniho 17/C, 82016 Bratislava, Slovakia.
700    1_
$a Straka, Ľ $u Clinical Pathology Presov, Ltd., Holleho 14, 08001 Presov, Slovakia.
700    1_
$a Konečný, M $u Department of Clinical Genetics, St. Elizabeth Cancer Institute, Heydukova 10, 812 50 Bratislava, Slovakia.
700    1_
$a Markus, J $u Department of Clinical Genetics, St. Elizabeth Cancer Institute, Heydukova 10, 812 50 Bratislava, Slovakia.
700    1_
$a D'Acunto, C W $u Department of Biochemistry and Microbiology, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Prague, Technicka 5, 16628 Prague, Czech Republic.
700    1_
$a Ruml, T $u Department of Biochemistry and Microbiology, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Prague, Technicka 5, 16628 Prague, Czech Republic.
700    1_
$a Böhmer, D $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia.
700    1_
$a Danihel, Ľudovít, $u Institute of Pathological Anatomy, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia. $d 1950- $7 nlk20000090334
700    1_
$a Repiská, V $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University in Bratislava, Sasinkova 4, 81108 Bratislava, Slovakia.
773    0_
$w MED00000336 $t Analytical cellular pathology (Amsterdam) $x 2210-7185 $g Roč. 2015, č. - (2015), s. 746856
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26114084 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20220215110431 $b ABA008
999    __
$a ok $b bmc $g 1113497 $s 934436
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 2015 $c - $d 746856 $e 20150531 $i 2210-7185 $m Analytical cellular pathology $n Anal Cell Pathol $x MED00000336
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...